Neurological Sciences

Article	Citations
Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients	244
The neurological manifestations of COVID-19: a review article	190
Neuromuscular presentations in patients with COVID-19	163
Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions	143
Spectrum of neurological complications following COVID-19 vaccination	141
A prospective clinical study of detailed neurological manifestations in patients with COVID-19	134
Dementia care and COVID-19 pandemic: a necessary digital revolution	134
Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital	117
Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports	76
West syndrome: a comprehensive review	73
New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases	70
Long-term neurological manifestations of COVID-19: prevalence and predictive factors	70
Early neurological manifestations of hospitalized COVID-19 patients	69
HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome	68
Neurological diseases as mortality predictive factors for patients with COVID-19: a retrospective cohort study	66
Dysphagia in neurological diseases: a literature review	65
Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2	62
Physical exercise effects on the brain during COVID-19 pandemic: links between mental and cardiovascular health	61
Neuropathologic findings of patients with COVID-19: a systematic review	59
Gender-related differences in migraine	59
Assessing disability and relapses in multiple sclerosis on tele-neurology	58
Direct and indirect neurological, cognitive, and behavioral effects of COVID-19 on the healthy elderly, mild-cognitive-impairment, and Alzheimer’s disease populations	57
Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients	55
Self-reported needs of patients with Parkinson’s disease during COVID-19 emergency in Italy	54
Seizure in patients with COVID-19	53

Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19	50
COVID-19, de novo seizures, and epilepsy: a systematic review	50
Hereditary spastic paraplegia	46
Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study	46
Brainstem involvement and respiratory failure in COVID-19	46
Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients	46
Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine	45
Diagnosis and treatment of Chiari malformation and syringomyelia in adults: international consensus document	44
Facing the digital divide into a dementia clinic during COVID-19 pandemic: caregiver age matters	43
Related risk factors associated with post-stroke fatigue: a systematic review and meta-analysis	42
Cumulative risk of stroke recurrence over the last 10 years: a systematic review and meta-analysis	42
An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID)	42
Management of COVID-19 in people with epilepsy: drug considerations	41
A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine	41
Qualitative smell/taste disorders as sequelae of acute COVID-19	41
Effect of home-based virtual reality training and telerehabilitation on balance in individuals with Parkinson disease, multiple sclerosis, and stroke: a systematic review and meta-analysis	41
Impact of quarantine due to COVID infection on migraine: a survey in Genova, Italy	41
The role of peripheral monocytes and macrophages in ischemic stroke	40
Early outcomes of migraine after erenumab discontinuation: data from a real-life setting	40
Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail	39
Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-6	39
Hereditary transthyretin amyloidosis overview	38
Anxiety and depression in Alzheimer’s disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline	38
Effect of lockdown on the management of ischemic stroke: an Italian experience from a COVID hospital	38
Cognitive impairment in multiple sclerosis: diagnosis and monitoring	37
Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review	37
Epilepsy and quality of life: what does really matter?	36
Neurological manifestations of coronavirus disease 2019: exploring past to understand present	36
Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab	35
The effect of obstructive sleep apnea on the increased risk of cardiovascular disease: a systematic review and meta-analysis	34
Functional neurological disorder after COVID-19 vaccination	34
Frequency and outcome of olfactory impairment and sinonasal involvement in hospitalized patients with COVID-19	34
Electroencephalography at the time of Covid-19 pandemic in Italy	32
Impact of COVID-19 on stroke admissions, treatments, and outcomes at a comprehensive stroke centre in the United Kingdom	32
The role of microglia in the development of neurodegeneration	32
Post-Traumatic Stress Disorder After Traumatic Brain Injury—A Systematic Review and Meta-Analysis	31
Effectiveness of ketogenic diet in treatment of patients with refractory chronic migraine	31
Subjective cognitive failures and their psychological correlates in a large Italian sample during quarantine/self-isolation for COVID-19	31
Investigation of the peripheral inflammation (neutrophil–lymphocyte ratio) in two neurodegenerative diseases of the central nervous system	30
Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19	29
Stroke and digital technology: a wake-up call from COVID-19 pandemic	29
New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report	29
Clinical and neurophysiological characterization of muscular weakness in severe COVID-19	29
Structural and functional connections between the autonomic nervous system, hypothalamic–pituitary–adrenal axis, and the immune system: a context and time dependent stress response network	29
Functional movement disorders in a patient with COVID-19	29
Current application of cannabidiol (CBD) in the management and treatment of neurological disorders	29
The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis	29
Screening for cognitive sequelae of SARS-CoV-2 infection: a comparison between the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA)	28
Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city—Itoigawa study	28
COVID-19-related strokes in adults below 55 years of age: a case series	27

The vessel density of the superficial retinal capillary plexus as a new biomarker in cerebral small vessel disease: an optical coherence tomography angiography study	27
New daily persistent headache after SARS-CoV-2 infection: a report of two cases	27
Peripheral neuropathy in Parkinson’s disease	26
Rising evidence for neurological involvement in COVID-19 pandemic	25
Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache	25
Life with chronic pain during COVID-19 lockdown: the case of patients with small fibre neuropathy and chronic migraine	25
Characteristics, onset, and evolution of neurological symptoms in patients with COVID-19	25
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic	25
Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine	25
Cardiovascular autonomic dysfunction after stroke	24
The impact of lockdown during SARS-CoV-2 outbreak on behavioral and psychological symptoms of dementia	24
Sex and gender differences in migraines: a narrative review	24
Incidence of stroke among Saudi population: a systematic review and meta-analysis	24
Letter to editor: CoVID-19 pandemic and sleep disorders—a web survey in Italy	24
Diagnosis and treatment of Chiari malformation type 1 in children: the International Consensus Document	24
Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review	24
Miller Fisher syndrome following Pfizer COVID-19 vaccine	24
Neuronavigation based 10 sessions of repetitive transcranial magnetic stimulation therapy in chronic migraine: an exploratory study	24
Chemotherapy and peripheral neuropathy	23
The Frontal Assessment Battery 20 years later: normative data for a shortened version (FAB15)	23
How to manage with telemedicine people with neuromuscular diseases?	23
Parkinson’s disease and virtual reality rehabilitation: cognitive reserve influences the walking and balance outcome	23
Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases	23
The emotional impact of COVID-19 outbreak in amyotrophic lateral sclerosis patients: evaluation of depression, anxiety and interoceptive awareness	23
Psychometrics and diagnostics of Italian cognitive screening tests: a systematic review	23
A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson’s disease	22
Neuralgic amyotrophy associated with COVID-19 infection: a case report and review of the literature	22
Clinical utility of home videos for diagnosing epileptic seizures: a systematic review and practical recommendations for optimal and safe recording	22
The stroke mothership model survived during COVID-19 era: an observational single-center study in Emilia-Romagna, Italy	22
NOTCH2NLC-related repeat expansion disorders: an expanding group of neurodegenerative disorders	22
Cognitive telerehabilitation in neurological patients: systematic review and meta-analysis	21
Prevalence of multiple sclerosis (MS) in Iran: a systematic review and meta-analysis	21
First motor seizure as presenting symptom of SARS-CoV-2 infection	21
Cognitive, behavioral, and psychological manifestations of COVID-19 in post-acute rehabilitation setting: preliminary data of an observational study	21
Assessment of gait and balance impairment in people with spinocerebellar ataxia using wearable sensors	21
Clinical presentation of strokes confined to the insula: a systematic review of literature	21
Dysregulation of IGF-1/GLP-1 signaling in the progression of ALS: potential target activators and influences on neurological dysfunctions	20
Effect of small vessel disease burden and lacunes on gait/posture impairment in Parkinson’s disease	20
Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study	20
An overview on amyotrophic lateral sclerosis and cadmium	20
The surgical treatment of epilepsy	20
Facemask headache: a new nosographic entity among healthcare providers in COVID-19 era	20
Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19	20
Why is delirium more frequent in the elderly?	20
Reliability of the six-minute walk test in individuals with stroke: systematic review and meta-analysis	20
Transcranial magnetic stimulation implementation on stroke prognosis	20
Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes	20
Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study	20
Functional autonomy in dementia of the Alzheimer’s type, mild cognitive impairment, and healthy aging: a meta-analysis	20
Thiazolidinedione use is associated with reduced risk of Parkinson’s disease in patients with diabetes: a meta-analysis of real-world evidence	19
ADEM anti-MOG antibody-positive after SARS-CoV2 vaccination	19
Electroencephalography during SARS-CoV-2 outbreak: practical recommendations from the task force of the Italian Society of Neurophysiology (SINC), the Italian League Against Epilepsy (LICE), and the I	19
Clinical features and cognitive sequelae in COVID-19: a retrospective study on N=152 patients	19
Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson’s disease: a pilot study	19
Evaluation of an upper limb robotic rehabilitation program on motor functions, quality of life, cognition, and emotional status in patients with stroke: a randomized controlled study	19
Age- and gender-related differences in the evolution of psychological and cognitive status after the lockdown for the COVID-19 outbreak: a follow-up study	19
Mechanical thrombectomy in acute ischemic stroke due to large vessel occlusion in the anterior circulation and low baseline National Institute of Health Stroke Scale score: a multicenter retrospective	19
Dynamic functional connectivity in temporal lobe epilepsy: a graph theoretical and machine learning approach	18
Neuroanatomical changes in early Parkinson’s disease with mild cognitive impairment: a VBM study; the Parkinson’s Disease Cognitive Impairment Study (PaCoS)	18
Erenumab efficacy in highly resistant chronic migraine: a real-life study	18
Frontal lobe metabolic alterations characterizing Parkinson’s disease cognitive impairment	18
Neovascularization and tissue regeneration by endothelial progenitor cells in ischemic stroke	18
Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment	18
The links between diabetes mellitus and amyotrophic lateral sclerosis	18
Headache and pleocytosis in CSF associated with COVID-19: case report	18
Clinical phenotypes of embolic strokes of undetermined source	18
Can Systemic Immune-Inflammation Index (SII) be a prognostic factor of Bell’s palsy patients?	18
Neuro-telehealth for fragile patients in a tertiary referral neurological institute during the COVID-19 pandemic in Milan, Lombardy	18
Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it?	18
Alzheimer’s disease: the controversial approval of Aducanumab	18
The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data	18
Neurological reasons for consultation and hospitalization during the COVID-19 pandemic	18
Endovascular treatment of ischemic large-vessel stroke due to infective endocarditis: case series and review of the literature	18
Neurological toll of COVID-19	17
Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience	17
“When should primary angiitis of the central nervous system (PACNS) be suspected?”: literature review and proposal of a preliminary screening algorithm	17
Do serum GDNF levels correlate with severity of Alzheimer’s disease?	17
Effects of saffron (Crocus sativus L.) on cognitive function. A systematic review of RCTs	17
Association of gender and age at onset with glucocerebrosidase associated Parkinson’s disease: a systematic review and meta-analysis	17
Impact of COVID-19 pandemic on acute stroke care: facing an epidemiological paradox with a paradigm shift	17

Clinical features and management of coexisting anti-N-methyl-D-aspartate receptor encephalitis and myelin oligodendrocyte glycoprotein antibody–associated encephalomyelitis: a case report and review o	17
Non-motor symptoms are associated with REM sleep behavior disorder in Parkinson’s disease: a systematic review and meta-analysis	17
Bell’s palsy following COVID-19 vaccination with high CSF antibody response	17
Deep brain stimulation in Huntington’s disease: a literature review	17
Covid-19-associated acute haemorrhagic leukoencephalomyelitis	17
Neurofilament light chain as a disease severity biomarker in ATTRv: data from a single-centre experience	17
Norms and standardizations in neuropsychology via equivalent scores: software solutions and practical guides	17
Diaphragmatic myoclonus due to SARS-CoV-2 infection	17
LncRNAs as putative biomarkers and therapeutic targets for Parkinson’s disease	17
The case of encephalitis in a COVID-19 pediatric patient	17
Impact of COVID-19 on neurological manifestations: an overview of stroke presentation in pandemic	17
A single-centre experience of intravenous thrombolysis for stroke in COVID-19 patients	17
The Italian technical/administrative recommendations for telemedicine in clinical neurophysiology	16
Social, professional and neuropsychiatric outcomes in patients with myasthenia gravis	16
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic	16
One year experience with erenumab: real-life data in 30 consecutive patients	16
Central nervous system adverse events after ChAdOx1 vaccination	16
Air pollution and multiple sclerosis: a comprehensive review	16
Factors affecting the behavior of children with ASD during the first outbreak of the COVID-19 pandemic	16
Contrast-induced encephalopathy mimicking total anterior circulation stroke: a case report and review of the literature	16
Parkinson’s disease and COVID-19: a systematic review and meta-analysis	16
Neurological manifestations and comorbidity associated with COVID-19: an overview	16
A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms	16
Pearls and pitfalls in brain functional analysis by event-related potentials: a narrative review by the Italian Psychophysiology and Cognitive Neuroscience Society on methodological limits and clinica	16
Neurotoxicity and safety of the rechallenge of immune checkpoint inhibitors: a growing issue in neuro-oncology practice	16
Hearing loss and dementia: radiologic and biomolecular basis of their shared characteristics. A systematic review.	16
Erenumab efficacy in chronic migraine and medication overuse: a real-life multicentric Italian observational study	16
Dealing with immune-mediated neuropathies during COVID-19 outbreak: practical recommendations from the task force of the Italian Society of Neurology (SIN), the Italian Society of Clinical Neurophysio	16
Acutely altered mental status as the main clinical presentation of multiple strokes in critically ill patients with COVID-19	16
Effectiveness of a dance-physiotherapy combined intervention in Parkinson’s disease: a randomized controlled pilot trial	16
A night of sleep deprivation alters brain connectivity and affects specific executive functions	15
The efficacy of ultrasound-guided stellate ganglion block in alleviating postoperative pain and ventricular arrhythmias and its application prospects	15
Sex influences clinical phenotype in frontotemporal dementia	15
Chronic fatigue syndrome and cognitive deficit are associated with acute-phase neuropsychiatric manifestations of COVID-19: A 9-month follow-up study	15
Chronic migraine in the first COVID-19 lockdown: the impact of sleep, remote working, and other life/psychological changes	15
COVID-19 presenting with agraphia and conduction aphasia in a patient with left-hemisphere ischemic stroke	15
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)	15
The Frontal Assessment Battery (FAB) and its sub-scales: validation and updated normative data in an Italian population sample	15
The influence of statin withdrawal and adherence on stroke outcomes	15
Brain microvascular occlusive disorder in COVID-19: a case report	15
Neurological manifestation of 22q11.2 deletion syndrome	15
A novel computed tomography perfusion-based quantitative tool for evaluation of perfusional abnormalities in migrainous aura stroke mimic	15
Effects of 2-year treatment with dimethyl fumarate on cognition and functional impairment in patients with relapsing remitting multiple sclerosis	15
Clinical, cerebrospinal fluid, and neuroimaging findings in COVID-19 encephalopathy: a case series	15
Gepants — a long way to cure: a narrative review	15
Influence of the gut microbiome on inflammatory and immune response after stroke	15
Shear wave elastography characteristics of upper limb muscle in rigidity-dominant Parkinson’s disease	15
Secular trends of ischaemic heart disease, stroke, and dementia in high-income countries from 1990 to 2017: the Global Burden of Disease Study 2017	15
MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development	15
Erenumab in 159 high frequency and chronic migraine patients: real-life results from the Bologna Headache Center	15
Urinary kynurenine as a biomarker for Parkinson’s disease	15
Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study	15
Which are the factors influencing NIV adaptation and tolerance in ALS patients?	15
Intra- and postoperative adverse events in awake craniotomy for intrinsic supratentorial brain tumors	14
Detection of MOG-IgG by cell-based assay: moving from discovery to clinical practice	14
Myelin oligodendrocyte glycoprotein-IgG-positive, steroid-responsive combined central and peripheral demyelination with recurrent peripheral neuropathy	14
Pupil dilation as an indicator of future thinking	14
Research progress on oxidative stress regulating different types of neuronal death caused by epileptic seizures	14
Tele-neuropsychological assessment tools in Italy: a systematic review on psychometric properties and usability	14
Daily exposure to digital displays may affect the clock-drawing test: from psychometrics to serendipity	14
Effects of safinamide on non-motor, cognitive, and behavioral symptoms in fluctuating Parkinson’s disease patients: a prospective longitudinal study	14
Factors associated with temporal window failure in transcranial Doppler sonography	14
Heart rate variability and fatigue in MS: two parallel pathways representing disseminated inflammatory processes?	14
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables	14
COVID-19 in patients with Down syndrome	14
Cyclophosphamide treatment in active multiple sclerosis	14
Short- and long-term motor outcome of STN-DBS in Parkinson’s Disease: focus on sex differences	14
Cognitive and behavioral manifestations in SARS-CoV-2 infection: not specific or distinctive features?	14
Bilateral optic neuritis after COVID vaccination	14
Imaging and depression in multiple sclerosis: a historical perspective	14
High plasma levels of trimethylamine N-oxide are associated with poor outcome in intracerebral hemorrhage patients	14
ADEM post-Sars-CoV-2 infection in a pediatric patient with Fisher-Evans syndrome	14
Post-acute sequelae of SARS-CoV-2 infection (PASC): peripheral, autonomic, and central nervous system features in a child	14
Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?	14
Favourable course in a cohort of Parkinson’s disease patients infected by SARS-CoV-2: a single-centre experience	14
NEK1 mutations and the risk of amyotrophic lateral sclerosis (ALS): a meta-analysis	13
The clinical correlation of proinflammatory and anti-inflammatory biomarkers with Alzheimer disease: a meta-analysis	13
Improving care of chronic pain patients with spinal cord stimulator therapy amidst the opioid epidemic	13
Risk factors predicting recurrence of transient global amnesia	13
Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination	13
Duchenne muscular dystrophy newborn screening: the first 50,000 newborns screened in Taiwan	13
A novel PNPLA6 mutation in a Turkish family with intractable Holmes tremor and spastic ataxia	13
Eye movement especially vertical oculomotor impairment as an aid to assess Parkinson’s disease	13
A systematic review on the risk of neurodegenerative diseases and neurocognitive disorders in professional and varsity athletes	13
Critical illness neuropathy in severe COVID-19: a case series	13
Persistent chemosensory dysfunction in a young patient with mild COVID-19 with partial recovery 15 months after the onset	13
Effectiveness of pharmacologic treatment for dysphagia in Parkinson’s disease: a narrative review	13
The effectiveness of cognitive-motor training on reconstructing cognitive health components in older male adults, recovered from the COVID-19	13
Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization	13
Diagnosing herpes simplex-1 encephalitis at the time of COVID-19 pandemic	13
Validation of a short Italian version of the Barratt Impulsiveness Scale (BIS-15) in non-clinical subjects: psychometric properties and normative data	13
Vestibular migraine: the chameleon in vestibular disease	13
Headache after COVID-19 vaccination: updated report from the Italian Medicines Agency database	13
Regular physical activity postpones age of occurrence of first-ever stroke and improves long-term outcomes	13
Wearable haptic anklets for gait and freezing improvement in Parkinson’s disease: a proof-of-concept study	12